View Older Stories

May 5, 2026 12:28PM Alkermes (ALKS) PT Raised to $45 at Stifel

May 5, 2026 07:13AM Alkermes (ALKS) Tops Q1 EPS by 14c; offers guidance

Apr 14, 2026 07:00AM Alkermes publishes 56-week LYBALVI analysis on schizophrenia symptoms

Apr 10, 2026 06:52AM Alkermes (ALKS) PT Raised to $53 at Mizuho

Mar 24, 2026 08:52AM Alkermes (ALKS) PT Lowered to $43 at Piper Sandler

Mar 10, 2026 08:24AM Truist Securities Reiterates Buy Rating on Alkermes (ALKS): "remains one of our highest conviction BUY rated stocks"

Feb 26, 2026 06:39AM Alkermes (ALKS) PT Lowered to $43 at H.C. Wainwright

Feb 25, 2026 07:19AM Alkermes (ALKS) Misses Q4 EPS by 12c ; Offers Guidance

Jan 28, 2026 02:16AM Alkermes (ALKS) PT Raised to $47 at UBS

Jan 6, 2026 07:04AM Alkermes receives FDA breakthrough therapy designation for narcolepsy drug

Nov 20, 2025 06:40AM H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)

Nov 17, 2025 05:52AM Avadel board deems Lundbeck's $2.4 billion bid superior to Alkermes deal

Nov 17, 2025 04:19AM Alkermes (ALKS) PT Raised to $55 at Truist Securities

Nov 14, 2025 07:45AM Alkermes responds to competing offer for Avadel from Lundbeck

Nov 14, 2025 05:45AM Avadel receives $23 per share takeover bid from Lundbeck

Nov 13, 2025 04:37AM Mizuho on Alkermes (ALKS): 'See Attactive Buying Opportunity'

Nov 12, 2025 01:05PM BofA Securities Reiterates Neutral Rating on Alkermes (ALKS)

Nov 12, 2025 12:37PM TD Cowen on Alkermes (ALKS): 'Overall we see the update as solid'

Nov 12, 2025 10:52AM Stifel on Alkermes (ALKS): 'this still looks like a viable commercial product in NT2'

Nov 12, 2025 09:57AM Truist Securities Defends Alkermes (ALKS) Amid 10pct Drop: 'We are buyers of the weakness today'

Nov 11, 2025 06:05AM Truist Securities Starts Alkermes (ALKS) at Buy

Nov 5, 2025 12:22PM RBC Positive on Alkermes (ALKS): 'we would be buyers into strength and upcoming NT2 data'

Nov 5, 2025 08:03AM Truist Securities Comments on Centessa Pharmaceuticals (CNTA) Amid 18pct Drop

Nov 5, 2025 07:55AM Stifel: 'ALKS Shares Should Get a Boost on CNTA Disclosure'

Oct 28, 2025 03:19PM Alkermes (ALKS) PT Raised to $34 at BofA Securities

Oct 28, 2025 01:16PM Jefferies on Alkermes (ALKS) Earnings: 'Solid Q3 + FY guide raise'

Oct 28, 2025 07:02AM Alkermes (ALKS) Tops Q3 EPS by 11c

Oct 27, 2025 06:43AM Alkermes (ALKS) PT Raised to $45 at Mizuho

Oct 23, 2025 06:42AM H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)

Oct 22, 2025 03:19PM RBC Capital on Jazz Pharmaceuticals (JAZZ): 'we would be buyers on the potential upcoming positive ph.III zanidatimab data in GEA'

Oct 22, 2025 02:44PM Alkermes (ALKS) PT Raised to $47 at RBC Capital

Oct 20, 2025 09:43AM Alkermes (ALKS) PT Raised to $46 at UBS

Oct 8, 2025 06:41AM Mizuho Reiterates Outperform Rating on Alkermes (ALKS)

Oct 6, 2025 08:06AM Piper Sandler Reiterates Overweight Rating on Alkermes (ALKS)

Sep 30, 2025 07:04AM Stifel Reiterates Buy Rating on Alkermes (ALKS)

Sep 26, 2025 05:04AM RBC Capital Upgrades Alkermes (ALKS) to Outperform

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Sep 9, 2025 06:48AM H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)

Sep 8, 2025 07:20AM Stifel Reiterates Buy Rating on Alkermes (ALKS)

Aug 18, 2025 06:31AM Piper Sandler Reiterates Overweight Rating on Alkermes (ALKS)

Aug 14, 2025 07:55AM Stifel Reiterates Buy Rating on Alkermes (ALKS)

Jul 30, 2025 07:53AM Alkermes (ALKS) PT Raised to $42 at RBC Capital

Jul 29, 2025 03:34PM Alkermes (ALKS) PT Lowered to $33 at BofA Securities

Jul 29, 2025 07:01AM Alkermes (ALKS) Tops Q2 EPS by 16c

Jul 22, 2025 06:39AM H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)

Jul 21, 2025 03:03PM Alkermes (ALKS) PT Raised to $54 at Jefferies

Jul 21, 2025 10:29AM BofA Securities Reiterates Neutral Rating on Alkermes (ALKS)

Jul 21, 2025 06:52AM Stifel Reiterates Buy Rating on Alkermes (ALKS)

Jul 15, 2025 03:32AM Goldman Sachs Starts Alkermes (ALKS) at Buy

Jun 17, 2025 07:06AM Stifel Reiterates Buy Rating on Alkermes (ALKS)

View Older Stories